What your home oncologist should put in the handover letter
A handover letter is not a discharge summary. It is a working document that lets the receiving oncologist reconstruct your treatment history and decide what comes next. Ask your home oncologist to write it in English, or to approve a translation, and to include the information below. If your hospital uses a standard template, check that these items are present rather than assuming they are.
The letter should state the cancer diagnosis, date of diagnosis, stage, and any relevant pathology or molecular results. It should name the chemotherapy regimen exactly, including the generic drug names, the dose per administration, the route, and the planned interval between cycles. It should list every cycle already completed with dates, and the date the next cycle is due. Cumulative doses matter for drugs with known dose limits, so ask for those to be stated where relevant.
The letter should also summarise the response so far: imaging dates and findings, tumour marker trends if they are being used, and the clinical assessment of benefit or progression. It should list significant toxicities, grade, and what was done about them, including any dose reductions, delays, or supportive medicines. Finally, it should state what the home team recommends next and what it would want to know from the Chinese team.
A short cover note from you can help. State your main question in one or two sentences, for example whether the receiving hospital can continue the same regimen or whether it recommends reassessment first. That keeps the clinical review focused.
Records that are easy to forget but often change the decision
Several items are routinely left out of handover packets, and their absence can delay a decision or lead to repeated tests. Ask your home team to include the following where they exist.
Baseline and recent blood counts, liver and kidney function, and any cardiac or neurological assessments relevant to your regimen. If you have a central venous access device, include the insertion date, type, and any complications. If you have had a port or line removed, say so. If you are taking anticoagulants, steroids, or supportive medicines, list them with doses.
Pending results are a common gap. If a scan, biopsy, molecular test, or blood test has been ordered but not reported, say so explicitly and give the expected reporting route. The receiving team needs to know whether to wait for that result or proceed with what is available. Do not assume the Chinese hospital can retrieve it from your home hospital.
If you have had a previous allergic reaction or infusion-related reaction, include the drug, the timing, and how it was managed. If you have any infection or wound issue, include the current status and treatment. These details affect whether treatment can proceed safely and what monitoring is needed.
Keep a personal copy of the full packet. You may need to share it with more than one hospital, and you should be able to answer basic questions about your own treatment history.
What the receiving Chinese hospital needs to confirm before accepting you
Acceptance is a clinical decision made by the receiving hospital, not a booking step. The hospital will review your records and decide whether it can safely continue your chemotherapy, whether it needs additional tests, and whether it recommends a different approach. You should ask directly what its process is for reviewing overseas records and how it communicates the outcome.
Ask whether the hospital can continue the exact regimen your home team prescribed. If the same drugs are not available, or if the hospital prefers a different protocol, ask what alternatives it would consider and why. Do not assume that a drug available in your home country is available in China, or that the same brand or formulation is used. Availability and formulary decisions are hospital-specific.
Ask who will be responsible for dose adjustments if your blood counts or organ function change. Ask how toxicity will be monitored between cycles, what tests will be done, and how results will be shared with your home oncologist. Ask what happens if you need urgent care outside scheduled appointments. These are practical questions that affect safety and continuity.
Ask whether the hospital requires a formal second opinion or a multidisciplinary review before accepting you. If it does, ask what records it needs and whether it can review them remotely. A remote review can clarify whether travel is worthwhile, but it does not guarantee acceptance or final treatment clearance.
If you are considering a clinical trial, ask separately about eligibility. Trial enrolment is not the same as continuing standard chemotherapy, and it requires its own screening process. Do not assume that a hospital's willingness to review your case means you are eligible for a trial.
How to keep both oncology teams communicating
Cross-border communication works best when one person on each side is named and reachable. Ask your home oncologist who will respond to questions from China, and ask the Chinese hospital who will be your treating oncologist or contact point. Exchange email addresses or another secure channel, and agree on what information will be shared and how often.
A simple shared summary can reduce confusion. One page listing your diagnosis, regimen, cycle dates, current medicines, allergies, and pending tests is easier for both teams to use than a large file. Update it after each cycle and send it to both sides.
Language matters. If your home oncologist writes in a language other than English, ask for an English version or a certified translation. If the Chinese hospital works in Chinese, ask whether it can provide interpretation for clinical discussions. Do not rely on a family member to translate complex oncology decisions unless both teams agree that this is adequate.
Ask both teams to confirm in writing what was decided after each discussion. A short email summary is enough. This reduces the risk that one side assumes the other has taken responsibility for a dose change, a test, or a follow-up appointment.
If your home oncologist has specific concerns about continuing treatment in China, ask them to put those concerns in the handover letter. The receiving team can then address them directly rather than discovering them later.
Responsibilities that should be agreed before you travel
Before you travel, clarify who is responsible for what. The receiving hospital is responsible for assessing you, ordering tests, prescribing treatment, and managing complications during your care in China. Your home oncologist remains responsible for your overall cancer history and for care after you return, unless a different arrangement is agreed.
Ask your home oncologist whether they are willing to review results from China and advise on the next steps after you return. Ask the Chinese hospital what it will send back: a discharge summary, treatment records, imaging, and a plan for follow-up. Ask how long that will take and whether it will be in English.
Medication supply is a practical responsibility. Ask the Chinese hospital how it will provide chemotherapy and supportive medicines during your stay, and what you should bring with you. Do not assume that your home prescriptions can be filled in China or that medicines can be shipped across borders. Ask about legal restrictions and documentation for any medicines you carry.
Insurance and payment responsibilities should be clear before treatment starts. Ask the hospital what it requires for international patients and what your insurer needs. Keep copies of all receipts and reports.
If you have a central line or port, ask who will manage it in China and what arrangements are needed for dressing changes or complications. If you need home nursing or supportive care between cycles, ask whether the hospital can arrange it or whether you need to organise it separately.
A practical next step
Start by asking your home oncologist to prepare the handover letter and records described above. Then contact the Chinese hospital or a coordination service to ask how it reviews overseas chemotherapy records and what it needs to decide whether it can continue your care. An initial enquiry is free and does not commit you to treatment or to buying a proxy consultation.
If you would like help identifying a suitable hospital or preparing your records for review, you can send a brief summary of your situation through the enquiry form. The team can explain what information is missing and suggest a relevant next step. The hospital will make the clinical decision about acceptance and treatment.
For general information about chemotherapy planning in China, see the related reference page.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
